Adverum Biotechnologies Inc
NASDAQ:ADVM
Income Statement
Earnings Waterfall
Adverum Biotechnologies Inc
Revenue
|
3.6m
USD
|
Operating Expenses
|
-127.4m
USD
|
Operating Income
|
-123.8m
USD
|
Other Expenses
|
6.6m
USD
|
Net Income
|
-117.2m
USD
|
Income Statement
Adverum Biotechnologies Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
-56%
|
0
-5%
|
0
+85%
|
1
+54%
|
1
+30%
|
1
+8%
|
2
+94%
|
2
+50%
|
2
+3%
|
2
+5%
|
2
-22%
|
1
-25%
|
2
+14%
|
2
+9%
|
2
+3%
|
2
-1%
|
2
-14%
|
2
+2%
|
2
+23%
|
2
-20%
|
1
-14%
|
1
-35%
|
0
-64%
|
0
-22%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
8
N/A
|
8
N/A
|
8
N/A
|
8
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
4
N/A
|
4
N/A
|
4
N/A
|
4
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(4)
|
(7)
|
(9)
|
(16)
|
(25)
|
(33)
|
(39)
|
(46)
|
(49)
|
(56)
|
(58)
|
(57)
|
(56)
|
(118)
|
(68)
|
(69)
|
(61)
|
(62)
|
(70)
|
(74)
|
(75)
|
(77)
|
(73)
|
(66)
|
(69)
|
(77)
|
(91)
|
(101)
|
(118)
|
(130)
|
(145)
|
(154)
|
(153)
|
(156)
|
(152)
|
(156)
|
(155)
|
(153)
|
(142)
|
(135)
|
(127)
|
|
Selling, General & Administrative |
(2)
|
(2)
|
(4)
|
(6)
|
(8)
|
(11)
|
(15)
|
(20)
|
(22)
|
(26)
|
(26)
|
(25)
|
(24)
|
(24)
|
(23)
|
(22)
|
(21)
|
(18)
|
(23)
|
(23)
|
(25)
|
(25)
|
(23)
|
(25)
|
(28)
|
(32)
|
(35)
|
(39)
|
(45)
|
(52)
|
(63)
|
(65)
|
(63)
|
(62)
|
(54)
|
(58)
|
(56)
|
(53)
|
(52)
|
(49)
|
(50)
|
|
Research & Development |
(2)
|
(3)
|
(5)
|
(10)
|
(17)
|
(22)
|
(24)
|
(26)
|
(27)
|
(28)
|
(31)
|
(32)
|
(32)
|
(33)
|
(34)
|
(36)
|
(40)
|
(44)
|
(46)
|
(51)
|
(50)
|
(47)
|
(45)
|
(41)
|
(40)
|
(45)
|
(55)
|
(62)
|
(73)
|
(79)
|
(82)
|
(89)
|
(89)
|
(92)
|
(98)
|
(98)
|
(99)
|
(95)
|
(88)
|
(85)
|
(78)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(61)
|
(12)
|
(11)
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(2)
|
(2)
|
0
|
|
Operating Income |
(3)
N/A
|
(7)
-94%
|
(9)
-31%
|
(16)
-82%
|
(24)
-53%
|
(33)
-33%
|
(38)
-16%
|
(44)
-17%
|
(46)
-5%
|
(54)
-16%
|
(55)
-3%
|
(55)
+0%
|
(55)
+1%
|
(116)
-113%
|
(67)
+43%
|
(67)
0%
|
(59)
+12%
|
(60)
-2%
|
(68)
-13%
|
(72)
-6%
|
(73)
-2%
|
(76)
-4%
|
(72)
+5%
|
(66)
+9%
|
(69)
-4%
|
(77)
-12%
|
(90)
-18%
|
(101)
-12%
|
(118)
-17%
|
(123)
-4%
|
(138)
-12%
|
(147)
-7%
|
(145)
+1%
|
(156)
-7%
|
(152)
+2%
|
(156)
-2%
|
(155)
+0%
|
(149)
+4%
|
(138)
+7%
|
(132)
+5%
|
(124)
+6%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Non-Reccuring Items |
(2)
|
0
|
(2)
|
(2)
|
(0)
|
0
|
0
|
0
|
(2)
|
0
|
(51)
|
(51)
|
(61)
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
0
|
(3)
|
(2)
|
(2)
|
0
|
0
|
0
|
(0)
|
|
Total Other Income |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
4
|
4
|
5
|
5
|
4
|
4
|
4
|
3
|
2
|
2
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
3
|
4
|
5
|
6
|
6
|
|
Pre-Tax Income |
(5)
N/A
|
(7)
-31%
|
(11)
-64%
|
(19)
-66%
|
(25)
-36%
|
(33)
-31%
|
(38)
-14%
|
(44)
-15%
|
(47)
-8%
|
(53)
-12%
|
(105)
-97%
|
(105)
0%
|
(115)
-9%
|
(115)
-1%
|
(65)
+44%
|
(65)
+1%
|
(56)
+13%
|
(57)
-2%
|
(65)
-13%
|
(73)
-13%
|
(74)
-1%
|
(71)
+4%
|
(67)
+5%
|
(61)
+9%
|
(64)
-5%
|
(73)
-13%
|
(87)
-20%
|
(99)
-13%
|
(116)
-18%
|
(122)
-5%
|
(137)
-12%
|
(148)
-8%
|
(146)
+1%
|
(155)
-6%
|
(154)
+0%
|
(156)
-1%
|
(154)
+1%
|
(146)
+6%
|
(133)
+8%
|
(126)
+5%
|
(118)
+6%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
10
|
0
|
0
|
11
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
|
Income from Continuing Operations |
(5)
|
(7)
|
(11)
|
(19)
|
(25)
|
(33)
|
(38)
|
(44)
|
(47)
|
(53)
|
(105)
|
(105)
|
(114)
|
(114)
|
(64)
|
(64)
|
(46)
|
(47)
|
(54)
|
(62)
|
(73)
|
(70)
|
(66)
|
(61)
|
(64)
|
(73)
|
(87)
|
(99)
|
(118)
|
(123)
|
(138)
|
(149)
|
(146)
|
(155)
|
(154)
|
(156)
|
(155)
|
(146)
|
(133)
|
(126)
|
(117)
|
|
Net Income (Common) |
(5)
N/A
|
(7)
-31%
|
(14)
-110%
|
(22)
-51%
|
(29)
-31%
|
(36)
-27%
|
(38)
-4%
|
(44)
-15%
|
(47)
-8%
|
(53)
-12%
|
(105)
-97%
|
(105)
0%
|
(114)
-8%
|
(114)
-1%
|
(64)
+44%
|
(64)
+1%
|
(56)
+12%
|
(57)
-2%
|
(65)
-13%
|
(72)
-11%
|
(73)
-1%
|
(70)
+4%
|
(66)
+6%
|
(61)
+7%
|
(64)
-5%
|
(73)
-13%
|
(87)
-20%
|
(99)
-13%
|
(118)
-19%
|
(123)
-5%
|
(138)
-12%
|
(149)
-8%
|
(146)
+2%
|
(155)
-7%
|
(154)
+0%
|
(156)
-1%
|
(155)
+1%
|
(146)
+6%
|
(133)
+8%
|
(126)
+5%
|
(117)
+7%
|
|
EPS (Diluted) |
-0.07
N/A
|
-0.32
-357%
|
-0.67
-109%
|
-1.33
-99%
|
-2.46
-85%
|
-1.46
+41%
|
-1.48
-1%
|
-1.7
-15%
|
-1.86
-9%
|
-1.96
-5%
|
-3
-53%
|
-2.54
+15%
|
-3.14
-24%
|
-2.71
+14%
|
-1.49
+45%
|
-1.46
+2%
|
-1.28
+12%
|
-0.99
+23%
|
-1.02
-3%
|
-1.14
-12%
|
-1.18
-4%
|
-1.12
+5%
|
-1.05
+6%
|
-0.96
+9%
|
-1.01
-5%
|
-0.98
+3%
|
-1.08
-10%
|
-1.11
-3%
|
-1.38
-24%
|
-1.25
+9%
|
-1.4
-12%
|
-1.52
-9%
|
-1.48
+3%
|
-1.57
-6%
|
-1.56
+1%
|
-1.57
-1%
|
-1.56
+1%
|
-1.46
+6%
|
-1.33
+9%
|
-1.26
+5%
|
-11.62
-822%
|